Literature DB >> 32505186

PEEP levels in COVID-19 pneumonia.

Vasiliki Tsolaki1, Ilias Siempos2, Eleni Magira2, Stelios Kokkoris2, George E Zakynthinos3, Spyros Zakynthinos2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32505186      PMCID: PMC7275848          DOI: 10.1186/s13054-020-03049-4

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.
To the Editor: Recently, the Surviving Sepsis Campaign COVID-19 guidelines and ATS suggest that a ventilatory strategy complying with the ARDSnet protocol should be applied to manage COVID-19 pneumonia [1-3]. However, “COVID-19 lung” pathophysiology seems to be divergent from the “ARDS lung”; hence, heart-lung interactions may be more pronounced than initially considered [2, 3]. We studied 17 patients (March 20–April 14, 2020) treated in two Greek University Intensive Care Units. Patients had COVID-19 pneumonia fulfilling the Berlin criteria of acute respiratory distress syndrome (ARDS) and were on the 2nd or 3rd day of invasive mechanical ventilation. Positive end-expiratory pressure (PEEP) was set according to predefined criteria [1-3]. Mean tidal volume (± standard deviation) was 6.8 ± 0.9 ml/kg ideal body weight (469 ± 64 ml), respiratory rate was 29.5 ± 3.7 breaths/min, and the fraction of inspired oxygen was 82 ± 12%. After measuring respiratory mechanics, arterial blood gases, and hemodynamics, we decreased PEEP by 25–30% (other mechanical ventilation variables remained stable). We re-evaluated measurements (1 h later) focusing on the effects of PEEP reduction on respiratory mechanics, hemodynamics, and fluid balance in a 12-h window before and after the PEEP change. Mean PEEP reduction by 29% significantly increased respiratory system compliance and reduced hypercapnia, while oxygenation (PaO2/FiO2) did not worsen (Table 1). PEEP reduction was not accompanied by lung de-recruitment, as oxygenation was not deteriorated. Rather PEEP reduction decreased lung overdistension as interpreted by the increase in respiratory system compliance and decrease in dead space ventilation (reduced PaCO2). Concerning hemodynamics, PEEP reduction was followed by a substantial decrease in noradrenaline dose, most likely indicating improvement in cardiac output that allowed decrease in vasopressor dose, while blood pressure remained constant.
Table 1

Respiratory and hemodynamic data in 17 mechanically ventilated patients with COVID-19, before and after PEEP reduction

BeforeAfterDifference between before and after(95% CI)aP value
PEEP, cm H2O15.6 ± 1.711.1 ± 1.94.5 (4.0 to 5.0)< 0.001
PaO2/FiO2, mm Hg115.8 ± 30.5121.9 ± 26.3− 6.1 (− 13.8 to 1.6)0.11
PaCO2, mm Hg49.7 ± 10.442.9 ± 5.66.8 (3.4 to 10.1)0.001
Cst, ml/cm H2O60.0 ± 8.363.2 ± 7.4− 3.2 (− 4.9 to − 1.5)0.001
Noradrenaline, μg/kg/min0.21 ± 0.120.08 ± 0.080.13 (0.09 to 0.16)< 0.001
MAP, mm Hg67.2 ± 6.169.1 ± 2.6− 1.9 (− 4.4 to 0.5)0.11
Fluid balance, ml1980 ± 764b942 ± 331c1039 (760 to 1317)< 0.001

Data are expressed as mean ± standard deviation

aData are expressed as mean difference [95% confidence interval (CI)]; bfluid balance during 12 h before PEEP reduction; cfluid balance during 12 h following PEEP reduction

PEEP positive end-expiratory pressure, PaO partial pressure of arterial oxygen, FiO fraction of inspired oxygen, PaCO partial pressure of arterial carbon dioxide, Cst static compliance of the respiratory system, MAP mean arterial pressure

Respiratory and hemodynamic data in 17 mechanically ventilated patients with COVID-19, before and after PEEP reduction Data are expressed as mean ± standard deviation aData are expressed as mean difference [95% confidence interval (CI)]; bfluid balance during 12 h before PEEP reduction; cfluid balance during 12 h following PEEP reduction PEEP positive end-expiratory pressure, PaO partial pressure of arterial oxygen, FiO fraction of inspired oxygen, PaCO partial pressure of arterial carbon dioxide, Cst static compliance of the respiratory system, MAP mean arterial pressure Application of unnecessary high PEEP (i.e., when PEEP does not result in lung recruitment) increases transpulmonary pressures, forcing West Zone 3 lung regions to Zones 2 and 1. This phenomenon increases dead space ventilation, resulting in hypercapnia when minute ventilation remains constant. Pulmonary vascular resistance increases, leading to a variable degree of right ventricular dysfunction due to ventriculo-arterial uncoupling. PEEP effects may be exacerbated when the pulmonary vascular bed is injured, as in ARDS, where intravascular obstruction is observed due to thromboemboli [4]. A hypercoagulable state and extensive lung capillary thrombosis has also been reported in COVID-19 [5]. When lung compliance is relatively normal, substantial amount of the alveolar pressure is transmitted to the pleura. Therefore, relatively high PEEP in a non-recruitable lung with almost normal compliance may significantly increase pleural pressure and have a detrimental impact on hemodynamics by deteriorating venous return. A conservative or de-resuscitative fluid strategy is recommended in the management of patients with ARDS [6]. Yet, in our patients, a strategy of increased PEEP approximating the ARDSnet protocol was accompanied by substantial vasopressor dosage and 12-h fluid balance. PEEP de-escalation led to significant reduction of cumulative fluid balance during the following 12 h and a three-fold decrease of vasopressor dosage. Decreased need for vasopressors and better fluid management translates in increased cardiac output and organ perfusion accompanied with less fluid accumulation in the lungs. COVID-19 lung involvement is unique having a “pneumonia pattern” than being a typical “ARDS pattern” at least in the initial phase during the first days after intubation, and this was rather the case in our patient group [5]. Therefore, mechanical ventilation should be applied differently from the routinely followed ARDS protocol. Intensivists have to be cautious in discriminating between pneumonia and typical ARDS. Failure to discriminate between COVID-19 pneumonia and ARDS and adoption of erroneous ventilatory strategy may have detrimental effects on hemodynamics, resulting in organ hypoperfusion and ultimately multiorgan failure.
  6 in total

Review 1.  Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis.

Authors:  Jonathan A Silversides; Emmet Major; Andrew J Ferguson; Emma E Mann; Daniel F McAuley; John C Marshall; Bronagh Blackwood; Eddy Fan
Journal:  Intensive Care Med       Date:  2016-10-12       Impact factor: 17.440

2.  Diagnosis and Management of COVID-19 Disease.

Authors:  Shazia Jamil; Nick Mark; Graham Carlos; Charles S Dela Cruz; Jane E Gross; Susan Pasnick
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

3.  Management of COVID-19 Respiratory Distress.

Authors:  John J Marini; Luciano Gattinoni
Journal:  JAMA       Date:  2020-06-09       Impact factor: 56.272

4.  Pulmonary hypertension in severe acute respiratory failure.

Authors:  W M Zapol; M T Snider
Journal:  N Engl J Med       Date:  1977-03-03       Impact factor: 91.245

5.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

6.  Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).

Authors:  Waleed Alhazzani; Morten Hylander Møller; Yaseen M Arabi; Mark Loeb; Michelle Ng Gong; Eddy Fan; Simon Oczkowski; Mitchell M Levy; Lennie Derde; Amy Dzierba; Bin Du; Michael Aboodi; Hannah Wunsch; Maurizio Cecconi; Younsuck Koh; Daniel S Chertow; Kathryn Maitland; Fayez Alshamsi; Emilie Belley-Cote; Massimiliano Greco; Matthew Laundy; Jill S Morgan; Jozef Kesecioglu; Allison McGeer; Leonard Mermel; Manoj J Mammen; Paul E Alexander; Amy Arrington; John E Centofanti; Giuseppe Citerio; Bandar Baw; Ziad A Memish; Naomi Hammond; Frederick G Hayden; Laura Evans; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2020-03-28       Impact factor: 17.440

  6 in total
  19 in total

Review 1.  Early spontaneous breathing for acute respiratory distress syndrome in individuals with COVID-19.

Authors:  Friedrich Hohmann; Lisa Wedekind; Felicitas Grundeis; Steffen Dickel; Johannes Frank; Martin Golinski; Mirko Griesel; Clemens Grimm; Cindy Herchenhahn; Andre Kramer; Maria-Inti Metzendorf; Onnen Moerer; Nancy Olbrich; Volker Thieme; Astrid Vieler; Falk Fichtner; Jacob Burns; Sven Laudi
Journal:  Cochrane Database Syst Rev       Date:  2022-06-29

2.  Pathophysiology of COVID-19-associated acute respiratory distress syndrome.

Authors:  Vasiliki Tsolaki; George E Zakynthinos; Konstantinos Mantzarlis; Vasileios Vazgiourakis; Dimosthenis Makris
Journal:  Lancet Respir Med       Date:  2020-11-13       Impact factor: 30.700

3.  Coronavirus Disease 2019 and Acute Respiratory Distress Syndrome: Why the Intensivist Is More Important Than Ever.

Authors:  Maurizio Cereda; Clifford S Deutschman
Journal:  Crit Care Med       Date:  2020-12       Impact factor: 9.296

4.  Right ventricular dilation: The additive effect of mechanical ventilation on pulmonary embolism in Covid-19 patients.

Authors:  Vasiliki Tsolaki; George E Zakynthinos; Konstantinos Mantzarlis
Journal:  Thromb Res       Date:  2020-08-04       Impact factor: 3.944

Review 5.  [Treatment recommendations for mechanical ventilation of COVID‑19 patients].

Authors:  B Neetz; F J F Herth; M M Müller
Journal:  Gefasschirurgie       Date:  2020-09-18

6.  Renal failure in COVID-19 ARDS: Could it be partially avoided?

Authors:  George E Zakynthinos; Vasiliki Tsolaki
Journal:  Aust Crit Care       Date:  2021-02-11       Impact factor: 2.737

7.  RV dysfunction in Covid-19 ARDS: Is there a difference in the impact of mechanical ventilation and ECMO?

Authors:  Vasiliki Tsolaki; George E Zakynthinos
Journal:  Int J Cardiol       Date:  2021-01-28       Impact factor: 4.164

8.  High risk of patient self-inflicted lung injury in COVID-19 with frequently encountered spontaneous breathing patterns: a computational modelling study.

Authors:  Liam Weaver; Anup Das; Sina Saffaran; Nadir Yehya; Timothy E Scott; Marc Chikhani; John G Laffey; Jonathan G Hardman; Luigi Camporota; Declan G Bates
Journal:  Ann Intensive Care       Date:  2021-07-13       Impact factor: 6.925

Review 9.  The use of positive end expiratory pressure in patients affected by COVID-19: Time to reconsider the relation between morphology and physiology.

Authors:  Gaetano Perchiazzi; Mariangela Pellegrini; Elena Chiodaroli; Ivan Urits; Alan D Kaye; Omar Viswanath; Giustino Varrassi; Filomena Puntillo
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2020-07-18

10.  Can Open Source Hardware Mechanical Ventilator (OSH-MVs) initiatives help cope with the COVID-19 health crisis? Taxonomy and state of the art.

Authors:  Simone Mora; Fábio Duarte; Carlo Ratti
Journal:  HardwareX       Date:  2020-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.